ARTICLE | Company News
diaDexus, GTx deal
June 21, 2004 7:00 AM UTC
DiaDexus will screen clinical samples from patients in GTXI's completed Phase IIb trial who had high grade prostatic intraepithelial neoplasia (PIN), a premalignant lesion that can progress to prostat...